Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 03, 2021

SELL
$6.22 - $15.54 $124,400 - $310,800
-20,000 Closed
0 $0
Q3 2020

Oct 16, 2020

BUY
$1.82 - $5.87 $18,200 - $58,700
10,000 Added 100.0%
20,000 $97,000
Q2 2020

Jul 21, 2020

BUY
$1.41 - $2.61 $14,100 - $26,100
10,000 New
10,000 $19,000

Others Institutions Holding STIM

About Neuronetics, Inc.


  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $40.3M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track Nwam LLC Portfolio

Follow Nwam LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nwam LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nwam LLC with notifications on news.